Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do researchers quickly update shots to keep up with mutations?

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

A boy and a woman who were stabbed by a man at the Target store in downtown Los Angeles won a court order Wednesday directing the retail chain to produce software evidence regarding 20 similar ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

Flu season is emerging and, although the disease is not predicted to be as prominent as years past, doctors urge people to ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica is a writer on the Wellness team with a focus on health ...

The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to better target the current circulating variants in the community.

The Public Health Agency of Canada (PHAC) says updated vaccines from Moderna and Pfizer-BioNTech ... The updated mRNA vaccines target the Omicron subvariant known as KP.2. Based on Canadian ...